Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05232071
What this trial is testing

Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

Who this might be right for
NASH - Nonalcoholic SteatohepatitisDiabetes Mellitus, Type 2
Inventiva Pharma 39
Not applicableStudy completedNCT02528305
What this trial is testing

The Effect of HIT in Patients With Non-alcoholic Fatty Liver Disease/Steatohepatitis

Who this might be right for
Non-alcoholic SteatohepatitisNon-alcoholic Fatty Liver Disease
University of Bath 12
Not applicableUnknownNCT05654129
What this trial is testing

Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University Hospital, Toulouse 182
Not applicableActive Not RecruitingNCT04595474
What this trial is testing

Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisFibrosis, Liver+2 more
Joslin Diabetes Center 533
Large-scale testing (Phase 3)Study completedNCT00509418
What this trial is testing

Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Catalysis SL 60
Not applicableStudy completedNCT02983669
What this trial is testing

The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverFatty Liver, Nonalcoholic
Shiraz University of Medical Sciences 86
Not applicableUnknownNCT05695118
What this trial is testing

Body Composition and Fatty Liver Disease

Who this might be right for
Fatty Liver
Seoul National University Hospital 150
Post-approval studies (Phase 4)Study completedNCT01208649
What this trial is testing

Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Fatty Liver Disease
Ruhr University of Bochum 13
Not applicableUnknownNCT04074889
What this trial is testing

The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty Liver

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Universiti Kebangsaan Malaysia Medical Centre 48
Not applicableStudy completedNCT04774302
What this trial is testing

Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD

Who this might be right for
NAFLD
Clinique Pasteur 292
Testing effectiveness (Phase 2)Study completedNCT02443116
What this trial is testing

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
NGM Biopharmaceuticals, Inc 254
Not applicableStudy completedNCT00586885
What this trial is testing

Effects of Alanine in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Keith D Lindor, M.D. 9
Not applicableStudy completedNCT05044130
What this trial is testing

Postprandial VLDL-triglyceride Metabolism in Type 2 Diabetes Patients With and Without NAFLD

Who this might be right for
NAFLDType 2 Diabetes
University of Aarhus 17
Large-scale testing (Phase 3)Study completedNCT02068339
What this trial is testing

Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis

Who this might be right for
Non-alcholic Fatty Liver Disease
PharmaKing 283
Not applicableUnknownNCT05200156
What this trial is testing

Impact Of Choline in Patients With NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Ain Shams University 100
Not applicableLooking for participantsNCT06649162
What this trial is testing

Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy

Who this might be right for
Type 2 Diabetes
Boryung Pharmaceutical Co., Ltd 10,000
Not applicableUnknownNCT05708560
What this trial is testing

Relationship Between MAFLD and Liver Fibrosis Progression in Patients With Chronic Hepatitis B: a Multicenter Retrospective Cohort Study

Who this might be right for
Hepatitis B, Chronic
Erasmus Medical Center 800
Testing effectiveness (Phase 2)Study completedNCT05193916
What this trial is testing

A Phase II Clinical Trial of Chiglitazar for NASH

Who this might be right for
NASH
Chipscreen Biosciences, Ltd. 104
Not applicableStudy completedNCT06338449
What this trial is testing

The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease NAFLD
Xuzhou Medical University 40
Not applicableStudy completedNCT03978247
What this trial is testing

Signature Diagnostic of Non-alcoholic Steatohepatitis (NASH) by Infrared Light Spectroscopy

Who this might be right for
Obesity
Diafir 382
Next Page